Ambar Protein

  • Market Cap: Micro Cap
  • Industry: Edible Oil
  • ISIN: INE072V01017
  • NSEID:
  • BSEID: 519471
INR
188.20
5.7 (3.12%)
BSENSE

May 08

BSE+NSE Vol: 726

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

726 (-29.02%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

72.69%

Who are the top shareholders of the Ambar Protein?

06-Jun-2025

The top shareholders of Ambar Protein include Jyotsna Sudhir Vachhani with 11.87%, followed by public shareholder Godhani Shirish Patel at 2.43%. Individual investors collectively own 28.32%, with no mutual funds or foreign institutional investors holding shares.

The top shareholders of Ambar Protein primarily include its promoters, with Jyotsna Sudhir Vachhani holding the largest share at 11.87%. In terms of public shareholders, Godhani Shirish Patel is the highest, owning 2.43%. Additionally, individual investors collectively hold 28.32% of the company's shares. Notably, there are no mutual funds or foreign institutional investors currently holding shares in the company.

View full answer

Who are in the management team of Ambar Protein?

06-Jun-2025

As of March 2023, the management team of Ambar Protein includes Jayprakashbhai J Vachhani (Whole-time Director), Pradip C Khatani (Managing Director), and several non-executive and independent directors, totaling ten members responsible for the company's governance and management.

As of March 2023, the management team of Ambar Protein includes the following individuals:<BR><BR>1. Jayprakashbhai J Vachhani - Whole-time Director<BR>2. Pradip C Khatani - Managing Director<BR>3. Dashrathbhai A Patel - Non-Executive & Non-Independent Director<BR>4. Shobhababen J Vachhani - Non-Executive & Non-Independent Director<BR>5. Bharat Dasrathbhai Patel - Non-Executive & Non-Independent Director<BR>6. Shirishkumar Dashrathbhai Patel - Non-Executive & Non-Independent Director<BR>7. Meghalkumar Chakravarti Harishbhai - Non-Executive & Independent Director<BR>8. Parimal B Shah - Independent Director<BR>9. Pradipkumar Sevantilal Shah - Chairman & Independent Director<BR>10. Mehul Ashok Kumar Mehta - Company Secretary & Compliance Officer<BR><BR>This team comprises a mix of executive and non-executive directors, with various roles contributing to the governance and management of the company.

View full answer

Has Ambar Protein declared dividend?

06-Jun-2025

No Dividend History Available

Who are the peers of the Ambar Protein?

03-Jun-2025

Ambar Protein's peers include Marico, Patanjali Foods, AWL Agri Business, Gokul Agro, Sundrop Brands, Ambo Agritec, Diligent Industries, N K Industries, and Rajgor Castor. Gokul Agro leads in 1-year returns at 71.95%, while AWL Agri Business has the lowest at -27.15%, with Ambar Protein achieving a 1-year return of 41.72%.

Peers: The peers of Ambar Protein are Marico, Patanjali Foods, AWL Agri Busine., Gokul Agro, Sundrop Brands, Ambo Agritec, Diligent Indust., N K Industries, and Rajgor Castor.<BR><BR>Quality Snapshot: Excellent management risk is observed at Marico, while Average management risk is found at Patanjali Foods, Gokul Agro, Sundrop Brands, Ambo Agritec, and Rajgor Castor, and the rest. Below Average management risk is present at AWL Agri Busine. and Diligent Indust. N K Industries does not qualify. Growth is Excellent at Patanjali Foods, Gokul Agro, and Rajgor Castor, while Good growth is seen at AWL Agri Busine. and Diligent Indust., and the rest show Below Average or Average growth. Capital Structure is Excellent at Marico and Sundrop Brands, Good at Patanjali Foods, AWL Agri Busine., and Gokul Agro, while Below Average is noted at Ambo Agritec and Diligent Indust., and the rest.<BR><BR>Return Snapshot: Gokul Agro has the highest 1-year return at 71.95%, while AWL Agri Busine. has the lowest at -27.15%. Ambar Protein's 1-year return of 41.72% is significantly higher than AWL Agri Busine.'s. Additionally, Diligent Indust. and Ambo Agritec have negative six-month returns.

View full answer

What is the technical trend for Ambar Protein?

09-Jun-2025

As of June 3, 2025, Ambar Protein's trend has shifted to bullish, supported by strong daily moving averages and MACD, though the weekly RSI indicates some short-term weakness.

As of 3 June 2025, the technical trend for Ambar Protein has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The daily moving averages are bullish, and the weekly MACD is also bullish, reinforcing the positive momentum. Additionally, both the weekly and monthly Bollinger Bands are bullish, indicating potential upward price movement. However, the weekly RSI is bearish, suggesting some short-term weakness that could temper the bullish outlook. Overall, the strength of the bullish trend is supported by the KST, which is bullish on both weekly and monthly time frames.

View full answer

What does Ambar Protein do?

17-Jul-2025

Ambar Protein Industries Ltd manufactures and trades edible oils and oil cakes, with a market cap of INR 230 Cr and reported net sales of 1,278 Cr and a net profit of 25 Cr for the quarter ending March 2025. The company has a P/E ratio of 2.00, significantly lower than the industry average of 60.

Overview:<BR>Ambar Protein Industries Ltd is engaged in the manufacturing and trading of edible oils and oil cakes, operating within the micro-cap segment of the edible oil industry.<BR><BR>History:<BR>The company was incorporated on 31st December 1992, originally known as Ankur Protein Industries Limited. The latest quarterly results reported net sales and profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 1,278 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 25 Cr (Quarterly Results - Mar 2025)<BR>- Market-cap: INR 230 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 2.00<BR>- Industry P/E: 60<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.00<BR>- Return on Equity: 0.00%<BR>- Price to Book: 0.00<BR><BR>Contact Details:<BR>Address: Opp Bhagyoday Hotel Changodar, Sarkhej-Bavla Highway Sanand Ahmedabad Gujarat : 382210<BR>Tel: 91-02717-250220/221<BR>Email: ambarprotein@yahoo.in<BR>Website: http://www.ambarprotein.com

View full answer

How big is Ambar Protein?

24-Jul-2025

As of 24th July, Ambar Protein Industries Ltd has a market capitalization of 204.00 Cr, classifying it as a Micro Cap company, with net sales of 421.62 Cr and a net profit of 9.71 Cr reported in the latest four quarters. Specific values for Shareholder's Funds and Total Assets are not available.

As of 24th July, Ambar Protein Industries Ltd has a market capitalization of 204.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Ambar Protein reported net sales of 421.62 Cr and a net profit of 9.71 Cr.<BR><BR>The reporting period for the balance sheet data is the latest annual period, but specific values for Shareholder's Funds and Total Assets are not available.

View full answer

When is the next results date for Ambar Protein?

07-Aug-2025

The next results date for Ambar Protein is 14 August 2025.

The next results date for Ambar Protein is scheduled for 14 August 2025.

View full answer

How has been the historical performance of Ambar Protein?

17-Oct-2025

Ambar Protein has shown significant growth in net sales and profitability from March 2020 to March 2025, with net sales increasing from 284.36 crore to 421.62 crore and profit after tax rising from 1.25 crore to 9.65 crore. The company's earnings per share also improved from 2.17 to 16.78 during this period.

Answer:<BR>The historical performance of Ambar Protein shows a significant upward trend in net sales and profitability over the years, culminating in the fiscal year ending March 2025.<BR><BR>Breakdown:<BR>Ambar Protein's net sales increased from 284.36 crore in March 2020 to 421.62 crore in March 2025, reflecting a consistent growth trajectory. The total operating income followed a similar pattern, rising from 230.45 crore in March 2019 to 421.62 crore in March 2025. Despite rising raw material costs, which reached 395.02 crore in March 2025, the company managed to improve its operating profit, which rose to 15.76 crore in the same period, up from 6.03 crore in March 2020. Profit before tax also saw a substantial increase, reaching 13.03 crore in March 2025, compared to just 2.76 crore in March 2020. Consequently, profit after tax surged to 9.65 crore in March 2025, up from 1.25 crore in March 2020, indicating improved profitability margins. The earnings per share (EPS) reflected this positive trend, increasing from 2.17 in March 2020 to 16.78 in March 2025. Total assets grew from 49.35 crore in March 2020 to 70.50 crore in March 2025, while total liabilities also increased, reaching 70.50 crore in March 2025. Overall, Ambar Protein has demonstrated robust growth in sales and profitability over the years, positioning itself favorably in the market.

View full answer

Why is Ambar Protein Industries Ltd falling/rising?

09-May-2026

As of 08-May, Ambar Protein Industries Ltd's stock price is Rs 188.20, reflecting a 3.12% increase. Despite a challenging year-to-date performance, recent trading activity shows positive momentum and increased investor interest, suggesting a potential recovery phase.

As of 08-May, Ambar Protein Industries Ltd is experiencing a rise in its stock price, currently at Rs 188.20, which reflects an increase of Rs 5.7 or 3.12%. This upward movement can be attributed to several factors. Over the past week, the stock has shown a significant gain of 15.89%, outperforming the Sensex, which only increased by 0.54%. Additionally, the stock has performed well in the past month, rising by 6.93% while the Sensex declined by 0.30%.<BR><BR>Despite a challenging year-to-date performance, where the stock is down 22.82% compared to a 9.26% drop in the Sensex, today's trading activity indicates positive momentum. The stock opened lower, down 2.44%, but reached an intraday high of Rs 190, marking a 4.11% increase at its peak. Furthermore, there has been a notable rise in investor participation, with delivery volume on 07 May increasing by 205.53% against the 5-day average, suggesting growing interest in the stock.<BR><BR>While the stock has underperformed its sector by 0.38% today, the overall trading volume and the stock's performance relative to its moving averages indicate a potential recovery phase. The stock is trading above its 5-day, 20-day, and 50-day moving averages, which may signal a positive trend moving forward.

View full answer

Which are the latest news on Ambar Protein?

09-May-2026
No latest news for Ambar Protein found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Edible Oil

stock-summary
Market cap

INR 99 Cr (Micro Cap)

stock-summary
P/E

2.00

stock-summary
Industry P/E

36

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
125 Cr
(Quarterly Results - Dec 2025)
Net Profit:
2 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.81%
0%
-2.81%
6 Months
-34.87%
0%
-34.87%
1 Year
-3.49%
0%
-3.49%
2 Years
17.62%
0%
17.62%
3 Years
-30.64%
0%
-30.64%
4 Years
449.49%
0%
449.49%
5 Years
0%
0%
0.0%

Ambar Protein for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

21-Apr-2026 | Source : BSE

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Company Ambar Protein Industries Ltd
2 CIN NO. L15400GJ1992PLC018758
3 Report filed for FY 2025-2026
Details of the Current block (all figures in Rs crore):
4 2 - year block period (Specify financial years)* 2025-26 2026-27
5 Incremental borrowing done in FY (T)(a) 0.00
6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
7 Actual borrowing done through debt securities in FY (T)(c) 0.00
8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0
8Quantum of (d) which has been met from (c)(e)* 0
9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0


Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)2024-25 2025-26
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



Name of the Company Secretary :-MEHUL ASHOKKUMAR MEHTA
Designation :-COMPANY SECRETARY AND COMPLIANCE OFFICER
Name of the Chief Financial Officer :- DHIRAJ MOHANBHAI PANCHAL
Designation : -CFO

Date: 21/04/2026

Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

21-Apr-2026 | Source : BSE

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1Name of CompanyAmbar Protein Industries Ltd
2CIN NO.L15400GJ1992PLC018758
3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 12.22
4Highest Credit Rating during the previous FY NA
4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. YES



Name of the Company Secretary: MEHUL ASHOKKUMAR MEHTA
Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER
EmailId: AMBARINV@GMAIL.COM
Name of the Chief Financial Officer: DHIRAJ MOHANBHAI PANCHAL
Designation: CFO
EmailId: AMBARPROTEIN.FINANCE@GMAIL.COM

Date: 21/04/2026

Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

09-Apr-2026 | Source : BSE

Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

No Data Found

Valuation key factors

No Data Found

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Ā TurnedĀ 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Jyotsna Sudhir Vachhani (11.87%)

Highest Public shareholder

Shirishkumar Madhavjibhai Godhani (2.43%)

Individual Investors Holdings

24.5%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 11.88% vs -4.78% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -9.50% vs 166.67% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "124.92",
          "val2": "111.66",
          "chgp": "11.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.24",
          "val2": "2.49",
          "chgp": "30.12%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.50",
          "val2": "0.45",
          "chgp": "11.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.81",
          "val2": "2.00",
          "chgp": "-9.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.59%",
          "val2": "2.23%",
          "chgp": "0.36%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 25.79% vs 12.46% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -37.64% vs 116.18% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "228.94",
          "val2": "182.00",
          "chgp": "25.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.65",
          "val2": "7.17",
          "chgp": "-35.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.98",
          "val2": "1.12",
          "chgp": "-12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "2.75",
          "val2": "4.41",
          "chgp": "-37.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.03%",
          "val2": "3.94%",
          "chgp": "-1.91%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 20.43% vs 18.69% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -36.93% vs 100.83% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "353.86",
          "val2": "293.82",
          "chgp": "20.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7.89",
          "val2": "11.99",
          "chgp": "-34.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.48",
          "val2": "1.69",
          "chgp": "-12.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.56",
          "val2": "7.23",
          "chgp": "-36.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "2.23%",
          "val2": "4.08%",
          "chgp": "-1.85%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 25.09% vs -2.32% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 206.35% vs 12.10% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "421.62",
          "val2": "337.06",
          "chgp": "25.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.76",
          "val2": "7.22",
          "chgp": "118.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.27",
          "val2": "2.46",
          "chgp": "-7.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "9.65",
          "val2": "3.15",
          "chgp": "206.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.74%",
          "val2": "2.14%",
          "chgp": "1.60%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
124.92
111.66
11.88%
Operating Profit (PBDIT) excl Other Income
3.24
2.49
30.12%
Interest
0.50
0.45
11.11%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.81
2.00
-9.50%
Operating Profit Margin (Excl OI)
2.59%
2.23%
0.36%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 11.88% vs -4.78% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -9.50% vs 166.67% in Sep 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
228.94
182.00
25.79%
Operating Profit (PBDIT) excl Other Income
4.65
7.17
-35.15%
Interest
0.98
1.12
-12.50%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.75
4.41
-37.64%
Operating Profit Margin (Excl OI)
2.03%
3.94%
-1.91%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 25.79% vs 12.46% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -37.64% vs 116.18% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
353.86
293.82
20.43%
Operating Profit (PBDIT) excl Other Income
7.89
11.99
-34.20%
Interest
1.48
1.69
-12.43%
Exceptional Items
0.00
0.00
Standalone Net Profit
4.56
7.23
-36.93%
Operating Profit Margin (Excl OI)
2.23%
4.08%
-1.85%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 20.43% vs 18.69% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -36.93% vs 100.83% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
421.62
337.06
25.09%
Operating Profit (PBDIT) excl Other Income
15.76
7.22
118.28%
Interest
2.27
2.46
-7.72%
Exceptional Items
0.00
0.00
Standalone Net Profit
9.65
3.15
206.35%
Operating Profit Margin (Excl OI)
3.74%
2.14%
1.60%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 25.09% vs -2.32% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 206.35% vs 12.10% in Mar 2024

stock-summaryCompany CV
About Ambar Protein Industries Ltd stock-summary
stock-summary
Ambar Protein Industries Ltd
Micro Cap
Edible Oil
Ambar Protein Industries Limited, formerly known Ankur Protein Industries Limited was incorporated on 31st December, 1992 with the basic object of manufacturing edible/ non- edible oils, oil cakes and 'D' Oil Cake. The Company changed its name from Ankur Protein Industries Limited to Ambar Protein Industries Limited with ROC approval effective on September 30, 2015.
Company Coordinates stock-summary
Company Details
Opp Bhagyoday Hotel Changodar, Sarkhej-Bavla Highway Sanand Ahmedabad Gujarat : 382210
stock-summary
Tel: 91-02717-250220/221
stock-summary
ambarprotein@yahoo.in
Registrar Details
Ankur Protein Inds. Ltd., Panchratna Estate, Opp. Bhagyodaya Hotel, Ta. Sanand Changodar, Ahmedabad